Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Meguro

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Diabetes Investigation|June 24, 2025
Lean body mass index and the risk of diabetes onset: A nationwide epidemiological cohort studyKazuki Aoyama, Hidehiro Kaneko, Tatsuhiko Azegami, et al.
The Journal of Medical Investigation : JMI|October 27, 2024
Difference in the accuracy of the third-generation algorithm and the first-generation algorithm of FreeStyle Libre continuous glucose monitoring deviceTakashi Murata, Naoki Sakane, Yushi Hirota, et al.
Journal of Diabetes Investigation|February 27, 2025
Effect of administration and withdrawal of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, on renal protection in individuals with type 2 diabetes mellitus and diabetic nephropathy: A multicenter, single-arm study (RESTORE-nephropathy study)Ayako Shigeta, Masami Tanaka, Shu Meguro, et al.
International Journal of Endocrinology|September 26, 2013
Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic NephropathyShu Meguro, Yusuke Kabeya, Karin Tanaka, et al.
Endocrine Journal|March 6, 2015
Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetesKumiko Tanaka, Yoshifumi Saisho, Toshihide Kawai, et al.
Diabetology International|October 29, 2024
Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA studyShu Meguro, Naoki Sakane, Kiminori Hosoda, et al.
Diabetes, Obesity & Metabolism|November 2, 2025
Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims databaseKazuki Aoyama, Akira Okada, Hidehiro Kaneko, et al.
Journal of Diabetes Investigation|September 14, 2019
Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetesYuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, et al.
Journal of Diabetes Science and Technology|February 17, 2025
The Relationship Between the Percent Coefficient of Variation of Sensor Glucose Levels and the Risk of Severe Hypoglycemia or Non-Severe Hypoglycemia in Patients With Type 1 Diabetes: Post Hoc Analysis of the ISCHIA StudyTakashi Murata, Munehide Matsuhisa, Akio Kuroda, et al.
The Journal of Medical Investigation : JMI|April 23, 2026
Sex differences in the impact of structured education together with isCGM in individuals with type 1 diabetes:post hoc analysis of the ISCHIA studyShuichiro Saito, Yushi Hirota, Akane Yamamoto, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Diabetes Investigation|June 24, 2025
Lean body mass index and the risk of diabetes onset: A nationwide epidemiological cohort studyKazuki Aoyama, Hidehiro Kaneko, Tatsuhiko Azegami, et al.
The Journal of Medical Investigation : JMI|October 27, 2024
Difference in the accuracy of the third-generation algorithm and the first-generation algorithm of FreeStyle Libre continuous glucose monitoring deviceTakashi Murata, Naoki Sakane, Yushi Hirota, et al.
Journal of Diabetes Investigation|February 27, 2025
Effect of administration and withdrawal of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, on renal protection in individuals with type 2 diabetes mellitus and diabetic nephropathy: A multicenter, single-arm study (RESTORE-nephropathy study)Ayako Shigeta, Masami Tanaka, Shu Meguro, et al.
International Journal of Endocrinology|September 26, 2013
Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic NephropathyShu Meguro, Yusuke Kabeya, Karin Tanaka, et al.
Endocrine Journal|March 6, 2015
Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetesKumiko Tanaka, Yoshifumi Saisho, Toshihide Kawai, et al.
Diabetology International|October 29, 2024
Diurnal variation in the association between the scan frequency of isCGM and CGM metrics: post hoc analysis of the ISCHIA studyShu Meguro, Naoki Sakane, Kiminori Hosoda, et al.
Diabetes, Obesity & Metabolism|November 2, 2025
Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims databaseKazuki Aoyama, Akira Okada, Hidehiro Kaneko, et al.
Journal of Diabetes Investigation|September 14, 2019
Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetesYuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, et al.
Journal of Diabetes Science and Technology|February 17, 2025
The Relationship Between the Percent Coefficient of Variation of Sensor Glucose Levels and the Risk of Severe Hypoglycemia or Non-Severe Hypoglycemia in Patients With Type 1 Diabetes: Post Hoc Analysis of the ISCHIA StudyTakashi Murata, Munehide Matsuhisa, Akio Kuroda, et al.
The Journal of Medical Investigation : JMI|April 23, 2026
Sex differences in the impact of structured education together with isCGM in individuals with type 1 diabetes:post hoc analysis of the ISCHIA studyShuichiro Saito, Yushi Hirota, Akane Yamamoto, et al.
Pageof 6